Hemodialysis and Peritoneal Dialysis Market (2025 - 2035)

Hemodialysis and Peritoneal Dialysis Market Outlook from 2025 to 2035

The hemodialysis and peritoneal dialysis market is expanding significantly, driven by the rising prevalence of chronic kidney disease, growing geriatric population, and increasing demand for home-based renal care solutions. Continuous technological advancements in dialysis machines, consumables, and monitoring systems have enhanced treatment precision and patient comfort.

The market benefits from expanding reimbursement coverage and the establishment of specialized dialysis centers across both developed and developing economies. Increasing awareness about early renal disorder management and improved diagnostic capabilities are contributing to patient pool expansion.

While hemodialysis remains the dominant treatment modality, peritoneal dialysis is gaining attention for its convenience and lower infrastructure requirements. The future outlook is marked by innovation in biocompatible materials and portable dialysis systems that improve treatment outcomes and accessibility.

Quick Stats for Hemodialysis and Peritoneal Dialysis Market

• Hemodialysis and Peritoneal Dialysis Market Industry Value (2025): USD 113.6 billion
• Hemodialysis and Peritoneal Dialysis Market Forecast Value (2035): USD 266.4 billion
• Hemodialysis and Peritoneal Dialysis Market Forecast CAGR: 8.9%
• Leading Segment in Hemodialysis and Peritoneal Dialysis Market in 2025: Hemodialysis (61.4%)
• Key Growth Region in Hemodialysis and Peritoneal Dialysis Market: North America, Asia-Pacific, Europe
• Top Key Players in Hemodialysis and Peritoneal Dialysis Market: Fresenius Medical Care AG, Baxter, B. Braun Melsungen AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., DaVita, BD, Nikkiso Co., Ltd., Cantel Medical

Metric	Value
Hemodialysis and Peritoneal Dialysis Market Estimated Value in (2025 E)	USD 113.6 billion
Hemodialysis and Peritoneal Dialysis Market Forecast Value in (2035 F)	USD 266.4 billion
Forecast CAGR (2025 to 2035)	8.9%

Segmental Analysis

The market is segmented by Type, Product, and End Use and region. By Type, the market is divided into Hemodialysis and Peritoneal Dialysis. In terms of Product, the market is classified into Devices and Consumables. Based on End Use, the market is segmented into Hospital-Based and Home-Based. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Hemodialysis Segment

The hemodialysis segment dominates the type category, accounting for approximately 61.4% share of the market. This dominance is driven by its established clinical efficacy, availability of trained professionals, and widespread installation of hemodialysis units in healthcare facilities.

The segment benefits from technological advancements that have improved treatment efficiency, fluid balance control, and patient safety. Increasing investments in dialysis infrastructure and public health programs for kidney disease management further reinforce its leadership.

The availability of compact and home-use machines has also expanded accessibility for patients preferring self-administered therapy. With growing incidence of end-stage renal disease and expanding clinical networks, the hemodialysis segment is expected to maintain its strong position globally.

Insights into the Devices Segment

The devices segment leads the product category with approximately 57.6% share, supported by increasing adoption of advanced hemodialysis and peritoneal dialysis equipment. Innovations in automated systems, enhanced filtration membranes, and real-time monitoring have significantly improved operational efficiency.

The segment benefits from consistent demand from hospitals, clinics, and home-care settings for reliable, high-performance machines. Continuous R&D investments by medical device manufacturers are aimed at reducing treatment duration and improving patient experience.

The transition toward digital health integration, including remote monitoring capabilities, further strengthens the segment’s outlook. As healthcare systems emphasize quality outcomes and operational efficiency, the devices segment is anticipated to retain its leading market share.

Insights into the Hospital-Based Segment

The hospital-based segment holds approximately 68.3% share in the end-use category, reflecting the concentration of dialysis treatments within institutional settings equipped with specialized infrastructure. Hospitals provide comprehensive care under medical supervision, ensuring patient safety and treatment precision.

This segment’s dominance is further supported by the availability of skilled nephrologists, trained nursing staff, and emergency support systems. Reimbursement models favoring in-hospital treatments and the capacity to handle complex cases have reinforced its market share.

Despite the gradual growth of home-based therapies, hospitals remain the primary point of care for acute and chronic dialysis patients. With ongoing healthcare investments and rising patient admissions for renal care, the hospital-based segment is expected to sustain its leadership position throughout the forecast period.

Hemodialysis and Peritoneal Dialysis Market Overview

• Advancements in technology, such as wearable devices, are contributing to the escalating demand for renal replacement therapies. Consequently, there is likely to be more than a 2.34X surge in the sales of hemodialysis and peritoneal dialysis devices by 2035.
• The increasing prevalence of renal diseases coupled with highly developed healthcare systems is driving robust growth in the market for hemodialysis and peritoneal dialysis across Japan and South Korea. This positions them as formidable contenders against the United States and China.
• Hemodialysis and peritoneal dialysis product and service providers need to navigate the surfacing healthcare landscape with a keen focus on innovation, patient-centric solutions, and strategic partnerships to ensure they stay at the forefront.

Key Factors Influencing the Global Hemodialysis and Peritoneal Dialysis Market Growth

ESRD Epidemic Spurs Dialysis Concentrate Demand Growth! The primary catalyst driving the market's expansion is the rise in the incidence and prevalence of end-stage renal disease (ESRD).

• The number of patients with newly recorded ESRD grew from 94,466 to 134,862 between 2000 and 2020, when the incident count reached its peak, according to the USRDS Annual Data Report, 2025.
• There is likely to be an increasing demand for dialysis to sustain normal kidney function as renal disorders spread throughout the world. Renal-related illness prevalence is predicted to rise sharply with the world's aging population's fast expansion. During the forecast period, this is anticipated to drive a considerable growth rate in the peritoneal dialysis machines market.

Technological Breakthroughs Energize Dialysis Market Growth! Technological advancements in dialysis equipment and procedures are fueling the hemodialysis machines market expansion.

• Innovations like portable dialysis machines and wearable devices are enhancing patient convenience and treatment flexibility. For example, the NxStage System One hemodialysis machine was introduced which is genuinely portable and approved for use at home in the United States. Similarly, AWAK Technologies introduced AWAK PD, a wearable and ultraportable peritoneal dialysis.
• Improved biocompatibility of dialysis membranes and solutions is reducing the incidence of complications and enhancing treatment efficacy.

Positive Reimbursement Policies Spark Dialysis Adoption! Growing healthcare expenditure and reimbursement policies are supporting the kidney dialysis market growth.

• Governments and private insurers are increasingly covering dialysis costs, making treatment more accessible to a larger patient population. An estimated 74.2 million people worldwide receive dialysis, for which governments spend close to USD 57.1 billion annually, according to a 2020 National Library of Medicine report. Peritoneal dialysis costs around USD 4.8 billion of this total.
• Favorable reimbursement policies for dialysis services are incentivizing healthcare providers to invest in advanced dialysis technologies. Following the patient's payment of the annual deductible, Medicare covers 80% of the monthly cost of dialysis in the United States.

Kidney Health Awareness Spurs Dialysis Market Expansion! Increasing awareness about kidney health and the importance of early intervention is driving the hemodialysis and peritoneal dialysis market growth.

• A 2025 National Center for Biotechnology Information article states that over 10% of people worldwide suffer from chronic kidney disease (CKD). As the number of incidents rises, so does public awareness. Public health campaigns are highlighting the risk factors of kidney disease. This is leading to earlier diagnosis and treatment initiation.
• Patient advocacy groups and healthcare organizations are working to destigmatize dialysis and promote proactive management of kidney health. In addition to patient education and advocacy, the National Kidney Foundation, a nonprofit health organization in the United States, occasionally offers scholarships. Voices for Kidney Health is an advocacy community affiliated with the NKF.

Obstacles Compressing the Peritoneal Dialysis and Hemodialysis Market Revenue Trends

Dialysis patients face several primary causes of death, often related to vascular access problems, such as bleeding, infection, low blood pressure, nausea, hernia, hepatitis (B & C), and anemia. Additionally, heart illnesses, encompassing arrhythmic processes or sudden cardiac arrest, contribute to the challenges these patients may encounter. Pneumonia is a frequent side effect of peritoneal dialysis, often triggered by infections from the catheter. This restricts the implementation of dialysis treatments.

With many companies, the dialysis industry is quite competitive and varied. This market is populated by start-up, mid-tier, and tier-I companies. In this fiercely competitive industry, businesses are working to increase their market awareness.

Additionally, many businesses-especially start-ups and small businesses-struggle to thrive and keep up with the industry's growth because of the high capital required for product manufacture and marketing as well as the drawn-out regulatory clearance process. This could make it extremely difficult for a certain business to have a persistent innovation capacity across all market sectors.

Historical Market Study on Hemodialysis and Peritoneal Dialysis alongside Future Projections

From 2020 to 2025, the hemodialysis and peritoneal dialysis market showed impressive growth, boasting an 11.2% CAGR. During this period, renal disease and renal failure were on the rise due to a growing prevalence of diabetes and hypertension. This trend has contributed to the positive outlook of the hemodialysis and peritoneal dialysis industry.

Attributes	Quantitative Outlook
Global Hemodialysis & Peritoneal Dialysis Market Size (2025)	USD 94.7 billion
Historical CAGR (2020 to 2025)	11.2%

Short-term Analysis of the Hemodialysis and Peritoneal Dialysis Market

Despite the anticipated decrease in growth rate, the hemodialysis and peritoneal dialysis market global forecast sustained demand due to technological advancements in dialysis equipment and procedures. The introduction of hemodiafiltration, a more recent technique that more effectively removes medium and large water-soluble molecules by convection and diffusion, is anticipated to shake up the market's outlook.

Long-term Analysis of the Hemodialysis and Peritoneal Dialysis Market

The global trends in the hemodialysis and peritoneal dialysis industry spotlight the growing adoption of home-based dialysis solutions, alongside a shift toward personalized treatments designed to meet individual requirements. In June 2025, for the management of patients with either acute or long-term renal failure, the United States-based medical technology company Outset Medical constructed the Tablo® mobile hemodialyzer.

The preclinical technology known as implantable bioartificial kidney (BAK), which aspires to completely replace natural kidney functions, is being developed with the patient's needs in mind. This is expected to have a highly positive impact on the global demand for hemodialysis and peritoneal dialysis products in the long run.

Top Opportunities Awaiting for Hemodialysis and Peritoneal Dialysis Market Players

The adoption of value-based healthcare models is expected to present opportunities for market players to innovate and expand their offerings. It emphasizes outcomes and quality of care over traditional fee-for-service arrangements. Technology businesses can provide systems that support remote monitoring, predictive analytics, and data-driven decision-making. These enable clinicians to provide more individualized and effective treatment.

Hemodialysis and Peritoneal Dialysis Market Trends

• Peritoneal dialysis is gaining popularity as an alternative to hemodialysis among patients seeking greater flexibility and autonomy in their treatment.
• An evolving trend in the hemodialysis and peritoneal dialysis market is the increasing focus on telemedicine and remote patient monitoring technologies to enhance patient care and improve treatment outcomes.
• Sustainability concerns and environmental considerations are prompting dialysis providers to explore eco-friendly practices as well as adopt more efficient water and energy management solutions in their facilities.

Demand Analysis of Hemodialysis and Peritoneal Dialysis by Region

The North America hemodialysis and peritoneal dialysis market stands out as a dominant force. This is because the region boasts advanced healthcare infrastructure and a robust regulatory framework.

Europe is witnessing continuous and steady growth in demand for hemodialysis and peritoneal dialysis consumables. Advancements in technology adoption have LED to greater utilization of dialysis therapies.

The Asia Pacific hemodialysis and peritoneal dialysis industry is likely to progress significantly. This is because countries like China, South Korea, and Japan are spending more on healthcare infrastructure.

Country	United States
Forecasted CAGR (2025 to 2035)	9.2%
Projected Market Size by 2035	USD 43.5 billion

Country	United Kingdom
Forecasted CAGR (2025 to 2035)	9.7%
Projected Market Size by 2035	USD 9.9 billion

Country	China
Forecasted CAGR (2025 to 2035)	9.5%
Projected Market Size by 2035	USD 38.3 billion

Country	Japan
Forecasted CAGR (2025 to 2035)	10.3%
Projected Market Size by 2035	USD 27.5 billion

Country	South Korea
Forecasted CAGR (2025 to 2035)	11.3%
Projected Market Size by 2035	USD 15.8 billion

Increasing Incidence of ESRD Drives Hemodialysis and Peritoneal Dialysis Adoption in the United States

Demand for peritoneal and hemodialysis dialysis equipment in the United States is set to rise with an anticipated CAGR of 9.2% through 2035. Key factors influencing hemodialysis and peritoneal dialyzer demand include:

• End-stage renal disease (ESRD) affects about 500,000 individuals in the United States. Decreased quality of life and early mortality are still predominantly caused by the onset of chronic kidney disease. The incidence of ESRD underscores the importance of both hemodialysis and peritoneal dialysis as essential treatment modalities.
• With approval from the Food and Drug Administration, Fresenius introduced a high-volume hemodiafiltration dialysis system to the United States in February 2025. According to Fresenius, about 174.20,000 of the regular hemodialysis machines that are now in existence at dialysis facilities across the country can be replaced by the 5008X hemodiafiltration system. This has the potential to reshape the hemodialysis market.

Rising Kidney Disease Cases Drive Demand for Hemodialysis and Peritoneal Dialysis in the United Kingdom

The United Kingdom hemodialysis and peritoneal dialysis market is expected to surge at a CAGR of 9.7% through 2035. The topmost dynamic forces supporting the hemodialysis and peritoneal dialysis adoption in the country include:

• About 3.2 million individuals in the United Kingdom have stages 1-5, and about 3.5 million have the more advanced stages of the disease (stages 3-5), according to estimates by Kidney Care UK. This highlights the continued importance of this market in providing vital care and support for individuals with kidney disease.
• The United Kingdom-based Quanta Dialysis Technologies secured USD 4 74.2 million in July 2020 to finance the commercial launch of a device that simplifies and lowers the cost of home hemodialysis for patients with kidney failure. This has significantly impacted the market by expanding access to home-based treatments.

Healthcare Infrastructure Boosts Demand for Hemodialysis and Peritoneal Dialysis in China

The China hemodialysis and peritoneal dialysis market is forecasted to inflate at a CAGR of 9.5% through 2035. Prominent factors backing up the hemodialysis machines market growth are:

• China has invested heavily in its dialysis centers and other healthcare infrastructure in order to address the growing number of people with chronic kidney disease. The government has implemented policies aimed at boosting the population's use of healthcare services, such as dialysis. Spending on healthcare has increased as a result, which has helped China's dialysis equipment market.
• The official introduction of the 74.2008 CAREsystem in China, which consists of the hemodialysis system 74.2008 and the related 74.2008 CAREset, was made public by Fresenius Medical Care in December 2025. This development has the potential to contribute to the market growth in China.

Advancements in Hyperphosphatemia Management Propel Dialysis Device Sales in Japan

Sales of hemodialysis and peritoneal dialysis equipment in Japan are estimated to record a CAGR of 10.3% through 2035. The primary factors bolstering the market size are:

• Over 2,000 persons per million are affected with ESRD in Japan. Japan has the highest rate of ESRD frequency and severity worldwide. This high prevalence of end-stage renal disease underscores the significant demand for dialysis treatments, including hemodialysis and peritoneal dialysis.
• Japan-based pharmaceutical company Kyowa Kirin announced in February 2025 that Phozevel Tablets are going to be available for purchase in Japan to help dialysis patients with chronic renal disease manage their hyperphosphatemia. This represents a significant advancement in the management of hyperphosphatemia among dialysis patients in Japan.

Increasing Demand for Dialysis Treatments Propels South Korea's Market Forward

The market in South Korea is likely to exhibit a CAGR of 11.3% through 2035. Reasons supporting the growth of the hemodialysis and peritoneal dialysis market in the country include:

• In South Korea, the proportion of ESRD patients is almost 70% that of the United States and 50% that of Japan. This suggests a significant demand for dialysis treatments in the country. This, in turn, has potential impacts on the hemodialysis and peritoneal dialysis industry in South Korea.
• More people are opting for home-based peritoneal dialysis because it's convenient, cost-effective, and gives patients more independence. This trend is gaining momentum, expanding the market as it meets the needs of patients seeking a flexible and efficient dialysis solution.

Hemodialysis and Peritoneal Dialysis Market Analysis by Segment

As far as the type of hemodialysis and peritoneal dialysis is concerned, the hemodialysis segment is likely to dominate through 2035, registering a CAGR of 8.7%. Similarly, the device segment is expected to lead the revenue share of hemodialysis and peritoneal dialysis in terms of product, with a projected CAGR of 8.4% through 2035.

Segment	Forecasted CAGR (2025 to 2035)
Hemodialysis	8.7%
Device	8.4%

Healthcare Professionals and Patients Prefer Hemodialysis for Its Effectiveness

The hemodialysis segment is anticipated to lead the way, holding an impressive hemodialysis and peritoneal dialysis market share. Here are a few key factors that contribute to hemodialysis’ acceptance in the market:

• Hemodialysis is preferred because it is more widely available at medical institutions across the world and can thus be accessed by a broader spectrum of patients.
• Healthcare professionals and patients favor hemodialysis because of its proven effectiveness and dependability in effectively eliminating waste materials and excess fluids from circulation.
• Hemodialysis is often perceived as a more effective treatment option for patients with ESRD who require frequent dialysis sessions to maintain their health and well-being.

Dialysis Devices Lead the Market with Enhanced Efficiency and Patient Comfort

The device segment takes the top spot in the hemodialysis and peritoneal dialysis market, a dialysis equipment industry trend validated by factors such as:

• When compared with consumables, dialysis devices frequently have a longer lifespan, which makes it a more appealing investment for medical organizations looking for economical alternatives.
• Many healthcare facilities prefer in-house dialysis services, which require reliable and efficient dialysis devices to meet patient needs effectively.
• Continuous innovations in dialysis devices, such as improved efficiency, portability, and patient comfort, are attracting healthcare providers to invest more in these technologies.

Competitive Landscape

Hemodialysis and peritoneal dialysis market players employ diverse strategies to gain a competitive edge. Established players like Fresenius Medical Care and B. Braun Melsungen AG dominate, offering comprehensive services and advanced technology.

Meanwhile, in peritoneal dialysis, Baxter International leads with its innovative solutions for home-based treatment. Emerging players such as NxStage Medical and Medtronic are gaining traction, focusing on portable dialysis machines and simplifying treatment processes.

Recent Developments

• A pre-pivotal clinical trial to investigate the reliability and effectiveness of an upgraded Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device was revealed in June 2025 by AWAK Technologies and Singapore General Hospital (SGH).
• The FDA gave liberDi Ltd., an Israeli device firm, regulatory authorization in January 2025 to introduce a novel continuous ambulatory peritoneal dialysis system to the market. With liberDi's system, patients can carry out their daily dialysis tasks from the comfort of their home or place of work
• The commercial introduction of the SURDIAL™ DXHemodialysis System in the United States was announced by Nipro Medical Corporation in March of 2025. Modern hemodialysis equipment like SURDIAL™ DX is made to provide patients and doctors with the best possible dialysis therapy.

Top 5 Hemodialysis and Peritoneal Dialysis Market Players

• Baxter
• B. Braun Melsungen AG
• Fresenius Medical Care AG
• Medtronic
• Asahi Kasei Medical Co., Ltd.

Key Coverage in the Hemodialysis and Peritoneal Dialysis Market Research Report

• In-depth Analysis of Available Opportunities in the Hemodialysis and Peritoneal Dialysis Market
• Detailed Assessment of Dialysis Equipment Industry Trends
• Adjacent Study on the Dialysis Services Market and Continuous Renal Replacement Therapy Market
• Chronic Kidney Disease Treatment Outlook in North America, Europe, and Asia Pacific

Key Segments

By Type:

• Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

By Product:

• Devices
  • Machine
  • Dialyzer
  • Water Treatment System
  • Others
• Consumables
  • Bloodline
  • Concentrates
  • Catheters
  • Others

By End Use:

• Home-based
• Hospital-based

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• Middle East & Africa (MEA)